Efficacy and safety of tocilizumab in COVID-19 patients

In this retrospective study we assessed the efficacy and safety of tocilizumab in patients with critical or severe coronavirus disease 2019 (COVID-19). We enrolled 181 patients admitted to Huoshenshan Hospital (Wuhan, China) with confirmed COVID-19 between January 2020 and February 2020. Ninety-two...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Kai-Lian, Xu, Ying, Guo, Yu-Feng, Diao, Le, Kong, Xiang-Yu, Wan, Xiao-Jian, Zhao, Feng, Ning, Fang-Zheng, Wang, Li-Bing, Qiao, Fan, Zhao, Jiang-Man, Zhou, Jia-Huan, Zhong, Yue-Qian, Wu, Shou-Xin, Chen, Yi, Jin, Gang, Dong, Yu-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732317/
https://www.ncbi.nlm.nih.gov/pubmed/33031060
http://dx.doi.org/10.18632/aging.103988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732317/
https://www.ncbi.nlm.nih.gov/pubmed/33031060
http://dx.doi.org/10.18632/aging.103988

Ejemplares similares